Cargando…

The use of monocyte subset repartitioning by flow cytometry for diagnosis of chronic myelomonocytic leukaemia

Detalles Bibliográficos
Autores principales:	Murali, Aarya, Cross, Donna, Mollee, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791046/ https://www.ncbi.nlm.nih.gov/pubmed/33414421 http://dx.doi.org/10.1038/s41408-020-00401-3

Ejemplares similares

Practical limitations of monocyte subset repartitioning by multiparametric flow cytometry in chronic myelomonocytic leukemia
por: Pophali, Prateek A., et al.
Publicado: (2019)

Evaluation by Flow Cytometry of Mature Monocyte Subpopulations for the Diagnosis and Follow-Up of Chronic Myelomonocytic Leukemia
por: Picot, Tiphanie, et al.
Publicado: (2018)

Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosis
por: Patnaik, M M, et al.
Publicado: (2017)

Monocyte subsets to differentiate chronic myelomonocytic leukemia from reactive monocytosis
por: Hwang, Sang Mee, et al.
Publicado: (2020)

Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis
por: Tarfi, Sihem, et al.
Publicado: (2018)

Characterization of Human Monocyte Subsets by Whole Blood Flow Cytometry Analysis
por: Marimuthu, Rekha, et al.
Publicado: (2018)

Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML).
por: Stark, A. N., et al.
Publicado: (1987)

Decitabine/cedazuridine for chronic myelomonocytic leukaemia, myelodysplastic syndromes
Publicado: (2022)

Comparison of existing prognostic models in chronic myelomonocytic leukemia
por: Jian, Jin-Li, et al.
Publicado: (2020)

Tracking chronic myelomonocytic leukaemia diversity at the single cell level
por: Solary, Eric
Publicado: (2020)

Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia
por: Machherndl‐Spandl, Sigrid, et al.
Publicado: (2021)

Leukaemia cutis as a specific skin involvement in chronic myelomonocytic leukaemia and review of the literature: Acknowledgments
por: Qiao, Yanhong, et al.
Publicado: (2020)

A hierarchical approach in the diagnostic workflow of chronic myelomonocytic leukemia: Pivotal role of the “Mono‐dysplasia‐score” combined with flow cytometric quantification of monocyte subsets
por: Zhu, Jaja, et al.
Publicado: (2019)

Repartition of the cycles in 1994
por: Boillot, J, et al.
Publicado: (1994)

A case of mandibular osteomyelitis in a patient with chronic myelomonocytic leukaemia
por: Kojima, Yuki, et al.
Publicado: (2016)

FuGEFlow: data model and markup language for flow cytometry
por: Qian, Yu, et al.
Publicado: (2009)

A Case of Acquired Haemophilia A in a Patient with Chronic Myelomonocytic Leukaemia
por: Araki, Takeshi, et al.
Publicado: (2019)

Chronic myelomonocytic leukaemia stem cell transcriptomes anticipate disease morphology and outcome
por: Wiseman, Daniel H, et al.
Publicado: (2020)

Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia
por: Pophali, Prateek, et al.
Publicado: (2020)

Challenges of setting up flow cytometry for diagnosis of leukemia and lymphoma at Moi Teaching and Referral Hospital, Eldoret, Kenya
por: Teresa, Lotodo, et al.
Publicado: (2015)

Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma
por: Yabe, Mariko, et al.
Publicado: (2020)

Diagnosis and treatment of chronic myelomonocytic leukemia
por: Kwon, Jihyun
Publicado: (2021)

An Unbiased Flow Cytometry-Based Approach to Assess Subset-Specific Circulating Monocyte Activation and Cytokine Profile in Whole Blood
por: Kiefer, Jurij, et al.
Publicado: (2021)

A Flow Cytometry Panel for Differential Diagnosis of Mantle Cell Lymphoma from Atypical B-Chronic Lymphocytic Leukaemia
por: Mehrpouri, Mahdieh, et al.
Publicado: (2023)

Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry
por: Takács, Ferenc, et al.
Publicado: (2022)

Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
por: Merlevede, Jane, et al.
Publicado: (2016)

Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia
por: Palomo, Laura, et al.
Publicado: (2019)

Utility of flow cytometry screening before MRD testing in multiple myeloma
por: Panakkal, Vandana, et al.
Publicado: (2023)

EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental
por: Patnaik, Mrinal M., et al.
Publicado: (2018)

Utility of indium-111 platelet scintigraphy for understanding the mechanism of thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia
por: Durand, Pauline, et al.
Publicado: (2023)

Evidence of seasonality in the diagnosis of monocytic leukaemia
por: Eatough, J P
Publicado: (2002)

Chronic myelomonocytic leukemia presenting with polyserositis due to an immune-mediated monocyte activation
por: Imataki, Osamu, et al.
Publicado: (2014)

Expert consensus on the management of chronic lymphocytic leukaemia in Asia
por: Tse, Eric, et al.
Publicado: (2023)

Rapidly developing renal milk of calcium in a patient with myelomonocytic leukaemia
por: Morjaria, Anika, et al.
Publicado: (2014)

Transformation of cytogenetically normal chronic myelomonocytic leukaemia to an acute myeloid leukaemia and the emergence of a novel +13,+15 double trisomy resulting in an adverse outcome
por: McGrattan, Peter, et al.
Publicado: (2007)

Comment on “In vivo flow cytometry reveals a circadian rhythm of circulating tumor cells”
por: Williams, Amber L., et al.
Publicado: (2021)

1988 LPI beam studies: Repartition and responsibility
Publicado: (1987)

Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors
por: Geissler, K, et al.
Publicado: (2016)

Cell kinetics in leukaemia and solid tumours studied with in vivo bromodeoxyuridine and flow cytometry.
por: Riccardi, A., et al.
Publicado: (1989)

Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis
por: Kastritis, Efstathios, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3ogbjlnac437i75tnmptqqp1l7